We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+16.04%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.37B
AUM Growth
+$116M
Cap. Flow
-$66.2M
Cap. Flow %
-4.85%
Top 10 Hldgs %
50.3%
Holding
162
New
18
Increased
25
Reduced
17
Closed
18

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.31%
2 Healthcare 16.62%
3 Communication Services 11.1%
4 Financials 8.84%
5 Utilities 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARDX icon
26
Ardelyx
ARDX
$1.24B
$11.9M 0.87%
2,268,798
+114,614
+5% +$689K
IMTX icon
27
Immatics
IMTX
$1.28B
$11.1M 0.82%
1,050,000
DRTT
28
DELISTED
DIRTT Environmental Solutions Ltd. Common Shares
DRTT
$11M 0.81%
7,069,735
+551,735
+8% +$827K
PRVB
29
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$11M 0.81%
859,314
+259,314
+43% +$3.28M
TSLA icon
30
CALL
Tesla
TSLA
$1.29T
$10.7M 0.79%
75,000
-300,000
-80% -$35.4M
TGTX icon
31
TG Therapeutics
TGTX
$7.46B
$10.7M 0.78%
398,271
BRK.B icon
32
PUT
Berkshire Hathaway Class B
BRK.B
$1.12T
$10.6M 0.78%
50,000
YARW
33
Yarrow Bioscience, Inc. Common Stock
YARW
$25.3M
$9.91M 0.73%
1,658
+116
+8% +$677K
KO icon
34
PUT
Coca-Cola
KO
$372B
$9.87M 0.72%
200,000
KG
35
Kestrel Group
KG
$70.5M
$9.61M 0.7%
393,848
ONDK
36
DELISTED
On Deck Capital, Inc.
ONDK
$9.27M 0.68%
5,793,015
+3,079,711
+114% +$4.17M
ZG icon
37
Zillow
ZG
$8.47B
$9.14M 0.67%
90,000
MGTX icon
38
MeiraGTx Holdings
MGTX
$1.14B
$9.06M 0.66%
684,447
+268,573
+65% +$3.54M
FATE icon
39
Fate Therapeutics
FATE
$300M
$8.99M 0.66%
225,000
ROCC
40
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$8.71M 0.64%
884,603
CMLFU
41
DELISTED
CM Life Sciences, Inc. Unit
CMLFU
$7.85M 0.58%
+750,000
New +$7.89M
CERE
42
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$7.32M 0.54%
+700,000
New +$7.39M
DHT icon
43
DHT Holdings
DHT
$2.92B
$7.31M 0.54%
1,416,100
+180,100
+15% +$995K
APTO
44
DELISTED
Aptose Biosciences, Inc.
APTO
$7M 0.51%
2,593
+1,889
+268% +$4.71M
FENC icon
45
Fennec Pharmaceuticals
FENC
$351M
$6.73M 0.49%
1,110,000
NUVB icon
46
Nuvation Bio
NUVB
$2.24B
$6.72M 0.49%
+600,000
New +$6.48M
CMPR icon
47
Cimpress
CMPR
$2.49B
$6.57M 0.48%
87,436
VTR icon
48
CALL
Ventas
VTR
$46.6B
$6.29M 0.46%
150,000
VTR icon
49
PUT
Ventas
VTR
$46.6B
$6.29M 0.46%
150,000
-450,000
-75% -$18M
HOME
50
DELISTED
At Home Group Inc.
HOME
$6.1M 0.45%
410,793
-550,000
-57% -$7.27M

Similar funds

683 Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, 683 Capital Management held 162 positions worth $1.37B, up 9.3% from $1.25B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

683 Capital Management withdrew a net $66.2M in Q3 2020, closing 18 positions and reducing 17 holdings. Its most notable exit was Ventas, an estimated $10M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, 683 Capital Management opened a new position in FirstEnergy worth $64.2M.

  • 683 Capital Management's largest Q3 2020 buy was FirstEnergy: 2,236,409 shares worth $64.2M.
  • 683 Capital Management added most to Wells Fargo in Q3 2020, an estimated $20.2M increase.
  • 683 Capital Management's biggest Q3 2020 reduction was People Inc, cutting an estimated $139M.
  • 683 Capital Management fully exited Ventas in Q3 2020, selling an estimated $10M.
  • 683 Capital Management's ten largest holdings make up 50% of its $1.37B portfolio in Q3 2020.
  • 683 Capital Management opened 18 new positions and closed 18 in Q3 2020.
  • 683 Capital Management's portfolio value rose 9.3% quarter-over-quarter to $1.37B.

Based on 683 Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.